OMER – omeros corporation (US:NASDAQ)

News

CMS Assigns Permanent Reimbursement J-Code for YARTEMLEA® (narsoplimab-wuug)
Omeros (OMER) was upgraded by Zacks Research from "hold" to "strong-buy".
Omeros (OMER) was upgraded by Wall Street Zen from "sell" to "hold".
Omeros: Making The Bull Case On Q4 Earnings, Ahead Of Key Q1 Commercial Updates [Seeking Alpha]
Omeros Corporation (OMER) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com